TAK-003 vaccine is a live-attenuated vaccine containing weakened versions of the four serotypes of the virus that cause dengue.
TAK-003 is the second dengue vaccine to be prequalified by WHO. Developed by Takeda, it is a live-attenuated vaccine ...
Dengue is a vector-borne disease transmitted by the bite of an infected mosquito. (Image Credits: Pixabay) The World Health Organization (WHO) on Wednesday announced that it has prequalified new ...
The World Health Organisation (WHO) marked a significant milestone in the global fight against dengue fever with the prequalification of a new vaccine, TAK-003 on May 10, 2024. Developed by Takeda ...
The World Health Organisation (WHO) prequalified a new dengue vaccine TAK-003 on May 10. TAK-003, developed by Takeda, is ...
The prequalification of TAK-003 is an important step in the expansion of global access to dengue vaccines, as it is now eligible for procurement by UN agencies including UNICEF. Photo: AFP A new ...
A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue vaccine to be prequalified by WHO. Developed by Takeda, it ...
The World Health Organisation (WHO) marked a significant milestone in the global fight against dengue fever with the prequalification of a new vaccine, TAK-003 on May 10, 2024. Developed by Takeda, ...